Vincent-Philippe Lavallée
Vincent-Philippe Lavallée
CHU Sainte-Justine Research Center and Université de Montréal
Adresse e-mail validée de
Citée par
Citée par
Transcriptional basis of mouse and human dendritic cell heterogeneity
CC Brown, H Gudjonson, Y Pritykin, D Deep, VP Lavallée, A Mendoza, ...
Cell 179 (4), 846-863. e24, 2019
Regenerative lineages and immune-mediated pruning in lung cancer metastasis
AM Laughney, J Hu, NR Campbell, SF Bakhoum, M Setty, VP Lavallée, ...
Nature medicine 26 (2), 259-269, 2020
Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia
I Baccelli, Y Gareau, B Lehnertz, S Gingras, JF Spinella, S Corneau, ...
Cancer cell 36 (1), 84-99. e8, 2019
GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo
C Pabst, A Bergeron, VP Lavallée, J Yeh, P Gendron, GL Norddahl, ...
Blood, The Journal of the American Society of Hematology 127 (16), 2018-2027, 2016
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
VP Lavallée, I Baccelli, J Krosl, B Wilhelm, F Barabé, P Gendron, ...
Nature genetics 47 (9), 1030-1037, 2015
Cohesin members Stag1 and Stag2 display distinct roles in chromatin accessibility and topological control of HSC self-renewal and differentiation
AD Viny, RL Bowman, Y Liu, VP Lavallée, SE Eisman, W Xiao, ...
Cell stem cell 25 (5), 682-696. e8, 2019
Expression of immunoproteasome genes is regulated by cell-intrinsic and–extrinsic factors in human cancers
A Rouette, A Trofimov, D Haberl, G Boucher, VP Lavallée, G D’Angelo, ...
Scientific reports 6 (1), 34019, 2016
Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
NA McNeer, J Philip, H Geiger, RE Ries, VP Lavallee, M Walsh, M Shah, ...
Leukemia 33 (8), 1934-1943, 2019
Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors
VP Lavallée, J Krosl, S Lemieux, G Boucher, P Gendron, C Pabst, I Boivin, ...
Blood, The Journal of the American Society of Hematology 127 (24), 3054-3061, 2016
EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations
VP Lavallée, P Gendron, S Lemieux, G D’Angelo, J Hébert, G Sauvageau
Blood, The Journal of the American Society of Hematology 125 (1), 140-143, 2015
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
L Simon, JF Spinella, CY Yao, VP Lavallée, I Boivin, G Boucher, ...
Blood, The Journal of the American Society of Hematology 135 (21), 1882-1886, 2020
Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets
A Maiga, S Lemieux, C Pabst, VP Lavallée, M Bouvier, G Sauvageau, ...
Blood Cancer Journal 6 (6), e431-e431, 2016
Genetic characterization of ABT-199 sensitivity in human AML
R Bisaillon, C Moison, C Thiollier, J Krosl, ME Bordeleau, B Lehnertz, ...
Leukemia 34 (1), 63-74, 2020
H3 K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations
B Lehnertz, YW Zhang, I Boivin, N Mayotte, E Tomellini, J Chagraoui, ...
Blood, The Journal of the American Society of Hematology 130 (20), 2204-2214, 2017
RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature
VP Lavallée, S Lemieux, G Boucher, P Gendron, I Boivin, RN Armstrong, ...
Blood, The Journal of the American Society of Hematology 127 (20), 2498-2501, 2016
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
FC Brown, E Still, RP Koche, CY Yim, S Takao, P Cifani, C Reed, ...
Cancer discovery 8 (4), 478-497, 2018
Venous thromboembolism in brain tumors: risk factors, molecular mechanisms, and clinical challenges
J Riedl, C Ay
Seminars in thrombosis and hemostasis 45 (04), 334-341, 2019
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML
S Garg, A Reyes-Palomares, L He, A Bergeron, VP Lavallée, S Lemieux, ...
Blood, The Journal of the American Society of Hematology 134 (3), 263-276, 2019
Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity
L Simon, VP Lavallée, ME Bordeleau, J Krosl, I Baccelli, G Boucher, ...
Clinical cancer research 23 (22), 6969-6981, 2017
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia
M Marquis, C Beaubois, VP Lavallée, M Abrahamowicz, C Danieli, ...
Blood cancer journal 8 (8), 68, 2018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20